{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T19:12:58Z","timestamp":1788462778661,"version":"build-2803163510"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"RIIM LPDP Grant and BRIN","award":["172\/IV\/KS\/11\/2023 and 6815\/UN1\/DITLIT\/Dit-Lit\/KP.01.03\/2023."],"award-info":[{"award-number":["172\/IV\/KS\/11\/2023 and 6815\/UN1\/DITLIT\/Dit-Lit\/KP.01.03\/2023."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metabolomics"],"DOI":"10.1007\/s11306-026-02459-9","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:56:34Z","timestamp":1783072594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolomics in breast cancer: insights into treatment responses, disease progression, and prognostic assessment"],"prefix":"10.1007","volume":"22","author":[{"given":"Dyah L.","family":"Dewi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elya","family":"Manik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ema","family":"Damayanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muslih","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Suratno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syam Budi","family":"Iryanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"issue":"6618","key":"2459_CR1","doi-asserted-by":"publisher","first-page":"eabj3510","DOI":"10.1126\/science.abj3510","volume":"378","author":"M Al-Habsi","year":"2022","unstructured":"Al-Habsi, M., Chamoto, K., Matsumoto, K., Nomura, N., Zhang, B., Sugiura, Y., Sonomura, K., Maharani, A., Nakajima, Y., Wu, Y., Nomura, Y., Menzies, R., Tajima, M., Kitaoka, K., Haku, Y., Delghandi, S., Yurimoto, K., Matsuda, F., Iwata, S., & Honjo, T. (2022). Spermidine activates mitochondrial trifunctional protein and improves antitumor immunity in mice. Science, 378(6618), eabj3510. https:\/\/doi.org\/10.1126\/science.abj3510","journal-title":"Science"},{"issue":"6","key":"2459_CR2","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","volume":"25","author":"A Angelin","year":"2017","unstructured":"Angelin, A., Gil-de-G\u00f3mez, L., Dahiya, S., Jiao, J., Guo, L., Levine, M. H., Wang, Z., Quinn, I. I. I., Kopinski, W. J., Wang, P. K., Akimova, L., Liu, T., Bhatti, Y., Han, T. R., Laskin, R., Baur, B. L., Blair, J. A., Wallace, I. A., Hancock, D. C., W. W., & Beier, U. H. (2017). Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metabolism, 25(6), 1282\u20131293e7. https:\/\/doi.org\/10.1016\/j.cmet.2016.12.018","journal-title":"Cell Metabolism"},{"issue":"11","key":"2459_CR4","doi-asserted-by":"publisher","first-page":"e0207474","DOI":"10.1371\/journal.pone.0207474","volume":"13","author":"M Arenas","year":"2018","unstructured":"Arenas, M., Rodr\u00edguez, E., Garc\u00eda-Heredia, A., Fern\u00e1ndez-Arroyo, S., Sabater, S., Robaina, R., Gasc\u00f3n, M., Rodr\u00edguez-Pla, M., Cabr\u00e9, N., Luciano-Mateo, F., Hern\u00e1ndez-Aguilera, A., Fort-Gallifa, I., Camps, J., & Joven, J. (2018). Metabolite normalization with local radiotherapy following breast tumor resection. PloS One, 13(11), e0207474. https:\/\/doi.org\/10.1371\/journal.pone.0207474","journal-title":"PloS One"},{"issue":"7","key":"2459_CR3","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1007\/s12094-019-02232-6","volume":"22","author":"M Arenas","year":"2020","unstructured":"Arenas, M., Fern\u00e1ndez-Arroyo, S., Rodr\u00edguez-Tom\u00e0s, E., Sabater, S., Murria, Y., Gasc\u00f3n, M., Amillano, K., Mel\u00e9, M., Camps, J., & Joven, J. (2020). Effects of radiotherapy on plasma energy metabolites in patients with breast cancer who received neoadjuvant chemotherapy. Clinical and Translational Oncology, 22(7), 1078\u20131085. https:\/\/doi.org\/10.1007\/s12094-019-02232-6","journal-title":"Clinical and Translational Oncology"},{"issue":"21","key":"2459_CR5","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.1158\/0008-5472.CAN-10-1319","volume":"70","author":"VM Asiago","year":"2010","unstructured":"Asiago, V. M., Alvarado, L. Z., Shanaiah, N., Gowda, G. A. N., Owusu-Sarfo, K., Ballas, R. A., & Raftery, D. (2010). Early detection of recurrent breast cancer using metabolite profiling. Cancer Research, 70(21), 8309\u20138318. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-1319","journal-title":"Cancer Research"},{"issue":"4","key":"2459_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0061578","volume":"8","author":"TF Bathen","year":"2013","unstructured":"Bathen, T. F. (2013). Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgery. PLOS ONE, 8(4), 1\u20137. https:\/\/doi.org\/10.1371\/journal.pone.0061578","journal-title":"PLOS ONE"},{"issue":"7","key":"2459_CR7","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1093\/chromsci\/bmac035","volume":"61","author":"K Beksac","year":"2023","unstructured":"Beksac, K., Re\u00e7ber, T., \u00c7etin, B., Alp, O., Kaynaro\u011flu, V., K\u0131r, S., & Nemutlu, E. (2023). GC-MS based metabolomics analysis to evaluate short-term effect of tumor removal on patients with early-stage breast cancer. Journal of Chromatographic Science, 61(7), 612\u2013618. https:\/\/doi.org\/10.1093\/chromsci\/bmac035","journal-title":"Journal of Chromatographic Science"},{"issue":"1","key":"2459_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s13167-025-00396-6","volume":"16","author":"M Bolliger","year":"2025","unstructured":"Bolliger, M., Wasinger, D., Brunmair, J., Hagn, G., Wolf, M., Preindl, K., Reiter, B., Bileck, A., Gerner, C., Fitzal, F., & Meier-Menches, S. M. (2025). Mass spectrometry-based analysis of eccrine sweat supports predictive, preventive and personalised medicine in a cohort of breast cancer patients in Austria. EPMA Journal, 16(1), 165\u2013182. https:\/\/doi.org\/10.1007\/s13167-025-00396-6","journal-title":"EPMA Journal"},{"key":"2459_CR9","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1093\/jn\/nxaa079","volume":"150","author":"ME Brosnan","year":"2020","unstructured":"Brosnan, M. E., & Brosnan, J. T. (2020). Histidine metabolism and function. The Journal of Nutrition, 150, 2570. https:\/\/doi.org\/10.1093\/jn\/nxaa079. S-2575S.","journal-title":"The Journal of Nutrition"},{"key":"2459_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jprot.2013.10.002","volume":"94","author":"J Budczies","year":"2013","unstructured":"Budczies, J., Brockm\u00f6ller, S. F., M\u00fcller, B. M., Barupal, D. K., Richter-Ehrenstein, C., Kleine-Tebbe, A., Griffin, J. L., Ore\u0161i\u010d, M., Dietel, M., Denkert, C., & Fiehn, O. (2013). Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism. Journal of Proteomics, 94, 279\u2013288. https:\/\/doi.org\/10.1016\/j.jprot.2013.10.002","journal-title":"Journal of Proteomics"},{"issue":"8","key":"2459_CR11","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/j.immuni.2025.07.007","volume":"58","author":"G B\u00fcndgen","year":"2025","unstructured":"B\u00fcndgen, G., Ulges, A., Pietruschka, J., Truong-Andrievici, N., Klein, M., Romaniuk, K., Schmitt, F., Hagen, M., Seebass, J. G., Zezlina, L., Stein, L., Probst, H. C., Distler, U., Tenzer, S., Lohoff, M., Romero-Olmedo, A. J., Mei, H., Bohn, T., Delacher, M., & Bopp, T. (2025). Polyamines regulate adaptive antitumor immunity by functional specialization of regulatory T cells. Immunity, 58(8), 2019\u20132034e11. https:\/\/doi.org\/10.1016\/j.immuni.2025.07.007","journal-title":"Immunity"},{"issue":"2","key":"2459_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/nbm.1762","volume":"25","author":"MD Cao","year":"2012","unstructured":"Cao, M. D., Sitter, B., Bathen, T. F., Bofin, A., L\u00f8nning, P. E., Lundgren, S., & Gribbestad, I. S. (2012). Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling. NMR in Biomedicine, 25(2), 369\u2013378. https:\/\/doi.org\/10.1002\/nbm.1762","journal-title":"NMR in Biomedicine"},{"key":"2459_CR13","doi-asserted-by":"publisher","unstructured":"Cardoso, M. R., Silva, A. A. R., Talarico, M. C. R., Sanches, P. H. G., Sfor\u00e7a, M. L., Rocco, S. A., Rezende, L. M., Quintero, M., Costa, T. B. B. C., Viana, L. R., Canevarolo, R. R., Ferracini, A. C., Ramalho, S., Gutierrez, J. M., Guimar\u00e3es, F., Tasic, L., Tata, A., Sarian, L. O., Cheng, L. L., & Derchain, S. F. M. (2022). Metabolomics by NMR combined with machine learning to predict neoadjuvant chemotherapy response for breast cancer. Cancers, 14(20). https:\/\/doi.org\/10.3390\/cancers14205055","DOI":"10.3390\/cancers14205055"},{"issue":"1","key":"2459_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41392-023-01380-0","volume":"8","author":"F Danzi","year":"2023","unstructured":"Danzi, F., Pacchiana, R., Mafficini, A., Scupoli, M. T., Scarpa, A., Donadelli, M., & Fiore, A. (2023). To metabolomics and beyond: a technological portfolio to investigate cancer metabolism. Signal Transduction and Targeted Therapy, 8(1), 137. https:\/\/doi.org\/10.1038\/s41392-023-01380-0","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"2459_CR34","doi-asserted-by":"publisher","unstructured":"de Freitas, A. J. A., Causin, R. L., Varuzza, M. B., Filho, H., Silva, C. M. T., da, V. D., de Souza, C. P., & Marques, M. M. C. (2021). Molecular biomarkers predict pathological complete response of neoadjuvant chemotherapy in breast cancer patients. Review Cancers, 13(21). https:\/\/doi.org\/10.3390\/cancers13215477","DOI":"10.3390\/cancers13215477"},{"issue":"10","key":"2459_CR15","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1021\/acs.jproteome.9b00316","volume":"18","author":"J Debik","year":"2019","unstructured":"Debik, J., Euceda, L. R., Lundgren, S., Gythfeldt, H., von der Garred, L., Borgen, \u00d8., Engebraaten, E., Bathen, O., T. F., & Giske\u00f8deg\u00e5rd, G. F. (2019). Assessing treatment response and prognosis by serum and tissue metabolomics in breast cancer patients. Journal of Proteome Research, 18(10), 3649\u20133660. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00316","journal-title":"Journal of Proteome Research"},{"issue":"1","key":"2459_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","volume":"19","author":"C Denkert","year":"2018","unstructured":"Denkert, C., von Minckwitz, G., Darb-Esfahani, S., Lederer, B., Heppner, B. I., Weber, K. E., Budczies, J., Huober, J., Klauschen, F., Furlanetto, J., Schmitt, W. D., Blohmer, J. U., Karn, T., Pfitzner, B. M., K\u00fcmmel, S., Engels, K., Schneeweiss, A., Hartmann, A., Noske, A., & Loibl, S. (2018). Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. The Lancet Oncology, 19(1), 40\u201350. https:\/\/doi.org\/10.1016\/S1470-2045(17)30904-X","journal-title":"The Lancet Oncology"},{"key":"2459_CR17","doi-asserted-by":"publisher","unstructured":"Derouane, F., van Marcke, C., Berli\u00e8re, M., Gerday, A., Fellah, L., Leconte, I., Van Bockstal, M. R., Galant, C., Corbet, C., & Duhoux, F. P. (2022). Predictive Biomarkers of response to neoadjuvant chemotherapy in breast cancer: current and future perspectives for precision medicine. Cancers, 14(16). https:\/\/doi.org\/10.3390\/cancers14163876","DOI":"10.3390\/cancers14163876"},{"key":"2459_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.csbj.2016.02.005","volume":"14","author":"AC Dona","year":"2016","unstructured":"Dona, A. C., Kyriakides, M., Scott, F., Shephard, E. A., Varshavi, D., Veselkov, K., & Everett, J. R. (2016). A guide to the identification of metabolites in NMR-based metabonomics\/metabolomics experiments. Computational and Structural Biotechnology Journal, 14, 135\u2013153. https:\/\/doi.org\/10.1016\/j.csbj.2016.02.005","journal-title":"Computational and Structural Biotechnology Journal"},{"issue":"1","key":"2459_CR19","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1038\/s41467-017-02101-2","volume":"8","author":"E Dornier","year":"2017","unstructured":"Dornier, E., Rabas, N., Mitchell, L., Novo, D., Dhayade, S., Marco, S., Mackay, G., Sumpton, D., Pallares, M., Nixon, C., Blyth, K., Macpherson, I. R., Rainero, E., & Norman, J. C. (2017). Glutaminolysis drives membrane trafficking to promote invasiveness of breast cancer cells. Nature Communications, 8(1), 2255. https:\/\/doi.org\/10.1038\/s41467-017-02101-2","journal-title":"Nature Communications"},{"key":"2459_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ejca.2017.01.017","volume":"75","author":"MJ Duffy","year":"2017","unstructured":"Duffy, M. J., Harbeck, N., Nap, M., Molina, R., Nicolini, A., Senkus, E., & Cardoso, F. (2017). Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM). European Journal of Cancer, 75, 284\u2013298. https:\/\/doi.org\/10.1016\/j.ejca.2017.01.017","journal-title":"European Journal of Cancer"},{"issue":"9472","key":"2459_CR21","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"Early Breast Cancer Trialists Collaborative Group","year":"2005","unstructured":"Early Breast Cancer Trialists Collaborative Group. (2005). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet, 365(9472), 1687\u20131717. https:\/\/doi.org\/10.1016\/S0140-6736(05)66544-0","journal-title":"Lancet"},{"issue":"5","key":"2459_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/BF00058152","volume":"8","author":"CA Elstad","year":"1990","unstructured":"Elstad, C. A., Meadows, G. G., & Abdallah, R. M. (1990). Specificity of the suppression of metastatic phenotype by tyrosine and phenylalanine restriction. Clinical & Experimental Metastasis, 8(5), 393\u2013416. https:\/\/doi.org\/10.1007\/BF00058152","journal-title":"Clinical & Experimental Metastasis"},{"issue":"3","key":"2459_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11306-025-02259-7","volume":"21","author":"AH Emwas","year":"2025","unstructured":"Emwas, A. H., Zacharias, H. U., Alborghetti, M. R., Gowda, G. A. N., Raftery, D., McKay, R. T., Chang, C., Saccenti, E., Gronwald, W., Schuchardt, S., Leiminger, R., Merzaban, J., Madhoun, N. Y., Iqbal, M., Alsiary, R. A., Shivapurkar, R., Pain, A., Shanmugam, D., Ryan, D., & Wishart, D. S. (2025). Recommendations for sample selection, collection and preparation for NMR-based metabolomics studies of blood. Metabolomics, 21(3), 66. https:\/\/doi.org\/10.1007\/s11306-025-02259-7","journal-title":"Metabolomics"},{"issue":"1\u20132","key":"2459_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/00365513.2018.1542541","volume":"79","author":"DT Eniu","year":"2019","unstructured":"Eniu, D. T., Romanciuc, F., Moraru, C., Goidescu, I., Eniu, D., Staicu, A., Rachieriu, C., Buiga, R., & Socaciu, C. (2019). The decrease of some serum free amino acids can predict breast cancer diagnosis and progression. Scandinavian Journal of Clinical and Laboratory Investigation, 79(1\u20132), 17\u201324. https:\/\/doi.org\/10.1080\/00365513.2018.1542541","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"key":"2459_CR25","doi-asserted-by":"publisher","unstructured":"Euceda, L. R., Haukaas, T. H., Giske\u00f8deg\u00e5rd, G. F., Vettukattil, R., Engel, J., Silwal-Pandit, L., Lundgren, S., Borgen, E., Garred, \u00d8., Postma, G., Buydens, L. M. C., B\u00f8rresen-Dale, A. L., Engebraaten, O., & Bathen, T. F. (2017). Evaluation of metabolomic changes during neoadjuvant chemotherapy combined with bevacizumab in breast cancer using MR spectroscopy. Metabolomics. https:\/\/doi.org\/10.1007\/s11306-017-1168-0","DOI":"10.1007\/s11306-017-1168-0"},{"issue":"6","key":"2459_CR26","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/jnci\/djz182","volume":"112","author":"JF Fahrmann","year":"2020","unstructured":"Fahrmann, J. F., Vykoukal, J., Fleury, A., Tripathi, S., Dennison, J. B., Murage, E., Wang, P., Yu, C. Y., Capello, M., Creighton, C. J., Do, K. A., Long, J. P., Irajizad, E., Peterson, C., Katayama, H., Disis, M. L., Arun, B., & Hanash, S. (2020). Association between plasma diacetylspermine and tumor spermine synthase with outcome in triple-negative breast cancer. Journal of the National Cancer Institute, 112(6), 607\u2013616. https:\/\/doi.org\/10.1093\/jnci\/djz182","journal-title":"JNCI: Journal of the National Cancer Institute"},{"issue":"10","key":"2459_CR27","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/sj.cdd.4401073","volume":"9","author":"F Fallarino","year":"2002","unstructured":"Fallarino, F., Grohmann, U., Vacca, C., Bianchi, R., Orabona, C., Spreca, A., Fioretti, M. C., & Puccetti, P. (2002). T cell apoptosis by tryptophan catabolism. Cell Death & Differentiation, 9(10), 1069\u20131077. https:\/\/doi.org\/10.1038\/sj.cdd.4401073","journal-title":"Cell Death & Differentiation"},{"issue":"1","key":"2459_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13059-024-03308-5","volume":"25","author":"W Fan","year":"2024","unstructured":"Fan, W., Zeng, S., Wang, X., Wang, G., Liao, D., Li, R., He, S., Li, W., Huang, J., Li, X., Liu, J., Li, N., & Hou, S. (2024). A feedback loop driven by H3K9 lactylation and HDAC2 in endothelial cells regulates VEGF-induced angiogenesis. Genome Biology, 25(1), 165. https:\/\/doi.org\/10.1186\/s13059-024-03308-5","journal-title":"Genome Biology"},{"issue":"1","key":"2459_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13058-024-01956-w","volume":"27","author":"Z Fang","year":"2025","unstructured":"Fang, Z., Ren, G., Ke, S., Xu, Q., Chen, Y., Shi, X., Guo, C., & Huang, J. (2025). Serum metabolomic profiling for predicting therapeutic response and toxicity in breast cancer neoadjuvant chemotherapy: A retrospective longitudinal study. Breast Cancer Research, 27(1), 2. https:\/\/doi.org\/10.1186\/s13058-024-01956-w","journal-title":"Breast Cancer Research"},{"issue":"4","key":"2459_CR30","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3109\/01480545.2014.981753","volume":"38","author":"AA Farshid","year":"2015","unstructured":"Farshid, A. A., Tamaddonfard, E., & Najafi, S. (2015). Effects of histidine and n-acetylcysteine on experimental lesions induced by doxorubicin in sciatic nerve of rats. Drug and Chemical Toxicology, 38(4), 436\u2013441. https:\/\/doi.org\/10.3109\/01480545.2014.981753","journal-title":"Drug and Chemical Toxicology"},{"issue":"12","key":"2459_CR31","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41568-022-00513-x","volume":"22","author":"MR Fernandes","year":"2022","unstructured":"Fernandes, M. R., Aggarwal, P., Costa, R. G. F., Cole, A. M., & Trinchieri, G. (2022). Targeting the gut microbiota for cancer therapy. Nature Reviews Cancer, 22(12), 703\u2013722. https:\/\/doi.org\/10.1038\/s41568-022-00513-x","journal-title":"Nature Reviews Cancer"},{"issue":"4","key":"2459_CR32","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s43018-021-00183-y","volume":"2","author":"GB Ferraro","year":"2021","unstructured":"Ferraro, G. B., Ali, A., Luengo, A., Kodack, D. P., Deik, A., Abbott, K. L., Bezwada, D., Blanc, L., Prideaux, B., Jin, X., Posada, J. M., Chen, J., Chin, C. R., Amoozgar, Z., Ferreira, R., Chen, I. X., Naxerova, K., Ng, C., Westermark, A. M., & Heiden, V., M. G (2021). Fatty acid synthesis is required for breast cancer brain metastasis. Nature Cancer, 2(4), 414\u2013428. https:\/\/doi.org\/10.1038\/s43018-021-00183-y","journal-title":"Nature Cancer"},{"issue":"6","key":"2459_CR33","doi-asserted-by":"publisher","first-page":"e21103","DOI":"10.1371\/journal.pone.0021103","volume":"6","author":"A Floegel","year":"2011","unstructured":"Floegel, A., Drogan, D., Wang-Sattler, R., Prehn, C., Illig, T., Adamski, J., Joost, H. G., Boeing, H., & Pischon, T. (2011). Reliability of serum metabolite concentrations over a 4-month period using a targeted metabolomic approach. PloS One, 6(6), e21103.","journal-title":"PloS One"},{"issue":"1","key":"2459_CR35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.tem.2025.04.008","volume":"37","author":"J F\u00fcreder","year":"2026","unstructured":"F\u00fcreder, J., Schernhammer, E. S., Eliassen, A. H., Sieri, S., & Warth, B. (2026). Metabolomics-enabled biomarker discovery in breast cancer research. Trends in Endocrinology & Metabolism, 37(1), 68\u201382. https:\/\/doi.org\/10.1016\/j.tem.2025.04.008","journal-title":"Trends in Endocrinology & Metabolism"},{"key":"2459_CR36","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.csbj.2020.05.021","volume":"18","author":"J Gal","year":"2020","unstructured":"Gal, J., Bailleux, C., Chardin, D., Pourcher, T., Gilhodes, J., Jing, L., Guigonis, J. M., Ferrero, J. M., Milano, G., Mograbi, B., Brest, P., Chateau, Y., Humbert, O., & Chamorey, E. (2020). Comparison of unsupervised machine-learning methods to identify metabolomic signatures in patients with localized breast cancer. Computational and Structural Biotechnology Journal, 18, 1509\u20131524. https:\/\/doi.org\/10.1016\/j.csbj.2020.05.021","journal-title":"Computational and Structural Biotechnology Journal"},{"issue":"11","key":"2459_CR37","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/nbm.2798","volume":"25","author":"GF Giske\u00f8deg\u00e5rd","year":"2012","unstructured":"Giske\u00f8deg\u00e5rd, G. F., Lundgren, S., Sitter, B., Fj\u00f8sne, H. E., Postma, G., Buydens, L. M. C., Gribbestad, I. S., & Bathen, T. F. (2012a). Lactate and glycine-potential MR biomarkers of prognosis in estrogen receptor-positive breast cancers. NMR in Biomedicine, 25(11), 1271\u20131279. https:\/\/doi.org\/10.1002\/nbm.2798","journal-title":"NMR in Biomedicine"},{"key":"2459_CR39","doi-asserted-by":"publisher","unstructured":"Guerra, G., Polymeropoulos, A., Venturelli, E., Huber, V., Segrado, F., Morelli, D., & Sieri, S. (2026). Investigating variability in metabolomics: A comparative study of analytical platforms and blood matrices using HPLC-HRMS. Molecules, 31(5). https:\/\/doi.org\/10.3390\/molecules31050814","DOI":"10.3390\/molecules31050814"},{"key":"2459_CR40","doi-asserted-by":"publisher","first-page":"ix10","DOI":"10.1093\/annonc\/mdy427.007","volume":"29","author":"J Ha","year":"2018","unstructured":"Ha, J., Kim, J. E., Jeong, J. H., Ahn, J. H., Jung, K. H., Lee, H. J., Gong, G., Chae, E. Y., Kim, H. H., Chung, I. Y., Ko, B. S., & Kim, S. B. (2018). Tumor-infiltrating lymphocytes and pathologic complete response among the patients with HER2 positive breast cancer receiving neoadjuvant docetaxel, carboplatin, trastuzumab and pertuzumab (TCHP): Single center experience. Annals of Oncology, 29, ix10. https:\/\/doi.org\/10.1093\/annonc\/mdy427.007","journal-title":"Annals of Oncology"},{"issue":"5","key":"2459_CR41","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"issue":"3","key":"2459_CR42","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10549-018-4801-3","volume":"170","author":"W Haque","year":"2018","unstructured":"Haque, W., Verma, V., Hatch, S., Suzanne Klimberg, V., Brian Butler, E., & Teh, B. S. (2018). Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy. Breast Cancer Research and Treatment, 170(3), 559\u2013567. https:\/\/doi.org\/10.1007\/s10549-018-4801-3","journal-title":"Breast Cancer Research and Treatment"},{"issue":"1","key":"2459_CR43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck, N., Penault-Llorca, F., Cortes, J., Gnant, M., Houssami, N., Poortmans, P., Ruddy, K., Tsang, J., & Cardoso, F. (2019). Breast cancer. Nature Reviews Disease Primers, 5(1), 66. https:\/\/doi.org\/10.1038\/s41572-019-0111-2","journal-title":"Nature Reviews Disease Primers"},{"issue":"6","key":"2459_CR44","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1158\/1078-0432.CCR-16-1153","volume":"23","author":"CD Hart","year":"2017","unstructured":"Hart, C. D., Vignoli, A., Tenori, L., Uy, G. L., Van To, T., Adebamowo, C., Hossain, S. M., Biganzoli, L., Risi, E., Love, R. R., Luchinat, C., & Di Leo, A. (2017). Serum metabolomic profiles identify ER-positive early breast cancer patients at increased risk of disease recurrence in a multicenter population. Clinical Cancer Research, 23(6), 1422\u20131431. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-1153","journal-title":"Clinical Cancer Research"},{"key":"2459_CR45","doi-asserted-by":"publisher","unstructured":"He, X., Gu, J., Zou, D., Yang, H., Zhang, Y., Ding, Y., & Teng, L. (2021). NMR-based metabolomics analysis predicts response to neoadjuvant chemotherapy for triple-negative breast cancer. Frontiers in Molecular Biosciences. https:\/\/doi.org\/10.3389\/fmolb.2021.708052","DOI":"10.3389\/fmolb.2021.708052"},{"issue":"1","key":"2459_CR46","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1186\/s12885-016-2766-3","volume":"16","author":"A Hennigs","year":"2016","unstructured":"Hennigs, A., Riedel, F., Gondos, A., Sinn, P., Schirmacher, P., Marm\u00e9, F., J\u00e4ger, D., Kauczor, H. U., Stieber, A., Lindel, K., Debus, J., Golatta, M., Sch\u00fctz, F., Sohn, C., Heil, J., & Schneeweiss, A. (2016). Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study. BMC Cancer, 16(1), 734. https:\/\/doi.org\/10.1186\/s12885-016-2766-3","journal-title":"Bmc Cancer"},{"key":"2459_CR47","doi-asserted-by":"publisher","unstructured":"Holmes, E., Wilson, I. D., & Nicholson, J. K. (2008). Metabolic phenotyping in health and disease. Cell, 134(5), 714\u2013717. https:\/\/doi.org\/10.1016\/j.cell.2008.08.026","DOI":"10.1016\/j.cell.2008.08.026"},{"issue":"6","key":"2459_CR48","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1158\/1055-9965.EPI-17-0627","volume":"27","author":"N Howlader","year":"2018","unstructured":"Howlader, N., Cronin, K. A., Kurian, A. W., & Andridge, R. (2018). Differences in breast cancer survival by molecular subtypes in the United States. Cancer Epidemiology Biomarkers & Prevention, 27(6), 619\u2013626. https:\/\/doi.org\/10.1158\/1055-9965.EPI-17-0627","journal-title":"Cancer Epidemiology Biomarkers & Prevention"},{"key":"2459_CR49","doi-asserted-by":"publisher","unstructured":"Huang, X., Liu, B., & Shen, S. (2025). Lipid metabolism in breast cancer: From basic research to clinical application. Cancers. https:\/\/doi.org\/10.3390\/cancers17040650","DOI":"10.3390\/cancers17040650"},{"issue":"3","key":"2459_CR50","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.4049\/jimmunol.1202702","volume":"191","author":"Z Husain","year":"2013","unstructured":"Husain, Z., Huang, Y., Seth, P., & Sukhatme, V. P. (2013). Tumor-derived lactate modifies antitumor immune response: Effect on myeloid-derived suppressor cells and NK cells. The Journal of Immunology, 191(3), 1486\u20131495. https:\/\/doi.org\/10.4049\/jimmunol.1202702","journal-title":"The Journal of Immunology"},{"issue":"6161","key":"2459_CR51","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1240527","volume":"342","author":"N Iida","year":"2013","unstructured":"Iida, N., Dzutsev, A., Stewart, C. A., Smith, L., Bouladoux, N., Weingarten, R. A., Molina, D. A., Salcedo, R., Back, T., Cramer, S., Dai, R. M., Kiu, H., Cardone, M., Naik, S., Patri, A. K., Wang, E., Marincola, F. M., Frank, K. M., Belkaid, Y., & Goldszmid, R. S. (2013). Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science, 342(6161), 967\u2013970. https:\/\/doi.org\/10.1126\/science.1240527","journal-title":"Science"},{"key":"2459_CR52","doi-asserted-by":"publisher","unstructured":"Irajizad, E., Wu, R., Vykoukal, J., Murage, E., Spencer, R., Dennison, J. B., Moulder, S., Ravenberg, E., Lim, B., Litton, J., Tripathym, D., Valero, V., Damodaran, S., Rauch, G. M., Adrada, B., Candelaria, R., White, J. B., Brewster, A., Arun, B., & Fahrmann, J. F. (2022). Application of artificial intelligence to plasma metabolomics profiles to predict response to neoadjuvant chemotherapy in triple-negative breast cancer. Frontiers in Artificial Intelligence. https:\/\/doi.org\/10.3389\/frai.2022.876100","DOI":"10.3389\/frai.2022.876100"},{"key":"2459_CR53","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jchromb.2018.11.029","volume":"1105","author":"P Jasbi","year":"2019","unstructured":"Jasbi, P., Wang, D., Cheng, S. L., Fei, Q., Cui, J. Y., Liu, L., Wei, Y., Raftery, D., & Gu, H. (2019). Breast cancer detection using targeted plasma metabolomics. Journal of Chromatography B, 1105, 26\u201337. https:\/\/doi.org\/10.1016\/j.jchromb.2018.11.029","journal-title":"Journal of Chromatography B"},{"key":"2459_CR54","doi-asserted-by":"publisher","unstructured":"Jim\u00e9nez-Franco, A., Jim\u00e9nez-Aguilar, J. M., Canela-Capdevila, M., Garc\u00eda-Pablo, R., Casta\u00f1\u00e9, H., Mart\u00ednez-Navidad, C., Araguas, P., Malav\u00e9, B., Benavides-Villarreal, R., Acosta, J. C., Onoiu, A. I., Somaiah, N., Camps, J., Joven, J., & Arenas, M. (2024). Preliminary metabolomics study suggests favorable metabolic changes in the plasma of breast cancer patients after surgery and adjuvant treatment. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12102196","DOI":"10.3390\/biomedicines12102196"},{"key":"2459_CR55","doi-asserted-by":"publisher","unstructured":"Jing, F., Jiang, L., Cao, Y., Tian, M., Qiu, J., Zhang, J., Tang, L., Lu, R., & Hu, Y. (2025). Plasma proteomics and metabolomics of aromatase inhibitors-related musculoskeletal syndrome in early breast cancer patients. Metabolites, 15(3). https:\/\/doi.org\/10.3390\/metabo15030153","DOI":"10.3390\/metabo15030153"},{"issue":"1","key":"2459_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.canlet.2013.09.011","volume":"343","author":"E Jobard","year":"2014","unstructured":"Jobard, E., Pontoizeau, C., Blaise, B. J., Bachelot, T., Elena-Herrmann, B., & Tr\u00e9dan, O. (2014). A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer. Cancer Letters, 343(1), 33\u201341. https:\/\/doi.org\/10.1016\/j.canlet.2013.09.011","journal-title":"Cancer Letters"},{"key":"2459_CR57","unstructured":"Kanaan, Y. M., Sampey, B. P., Beyene, D., Esnakula, A. K., Naab, T. J., Ricks-Santi, L. J., Dasi, S., Day, A., Blackman, K. W., Frederick, W., Copeland, R. L., Gabrielson, E., & Dewitty, R. L. (2014). Metabolic profile of triple-negative breast cancer in African\u2013American women reveals potential biomarkers of aggressive disease. Cancer Genomics & Proteomics, 11(6), 279\u2013294. http:\/\/cgp.iiarjournals.org\/content\/11\/6\/279.abstract."},{"issue":"8","key":"2459_CR58","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00432-025-06271-1","volume":"151","author":"P Kr\u00f3lewska-Daszczy\u0144ska","year":"2025","unstructured":"Kr\u00f3lewska-Daszczy\u0144ska, P., Englisz, A., Morawiec, M. L., Mi\u015bkiewicz, J., Go\u0142\u0119bski, M., & Mielczarek-Palacz, A. (2025). The assessment of breast cancer biomarkers in diagnosis, prognosis and treatment monitoring: Integrated analysis. Journal of Cancer Research and Clinical Oncology, 151(8), 233. https:\/\/doi.org\/10.1007\/s00432-025-06271-1","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"10","key":"2459_CR59","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nrclinonc.2017.74","volume":"14","author":"M Kwa","year":"2017","unstructured":"Kwa, M., Makris, A., & Esteva, F. J. (2017). Clinical utility of gene-expression signatures in early stage breast cancer. Nature Reviews Clinical Oncology, 14(10), 595\u2013610. https:\/\/doi.org\/10.1038\/nrclinonc.2017.74","journal-title":"Nature Reviews Clinical Oncology"},{"key":"2459_CR60","doi-asserted-by":"publisher","first-page":"17063","DOI":"10.1038\/cddiscovery.2017.63","volume":"3","author":"R Lappano","year":"2017","unstructured":"Lappano, R., Sebastiani, A., Cirillo, F., Rigiracciolo, D. C., Galli, G. R., Curcio, R., Malaguarnera, R., Belfiore, A., Cappello, A. R., & Maggiolini, M. (2017). The lauric acid-activated signaling prompts apoptosis in cancer cells. Cell Death Discovery, 3, 17063. https:\/\/doi.org\/10.1038\/cddiscovery.2017.63","journal-title":"Cell Death Discovery"},{"issue":"1","key":"2459_CR61","doi-asserted-by":"publisher","first-page":"14554","DOI":"10.1038\/srep14554","volume":"5","author":"P Lehouritis","year":"2015","unstructured":"Lehouritis, P., Cummins, J., Stanton, M., Murphy, C. T., McCarthy, F. O., Reid, G., Urbaniak, C., Byrne, W. L., & Tangney, M. (2015). Local bacteria affect the efficacy of chemotherapeutic drugs. Scientific Reports, 5(1), 14554. https:\/\/doi.org\/10.1038\/srep14554","journal-title":"Scientific Reports"},{"issue":"1","key":"2459_CR62","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1186\/s12885-019-6393-7","volume":"19","author":"TH Lende","year":"2019","unstructured":"Lende, T. H., Austdal, M., Bathen, T. F., Varhaugvik, A. E., Skaland, I., Gudlaugsson, E., Egeland, N. G., Lunde, S., Akslen, L. A., Jonsdottir, K., Janssen, E. A. M., S\u00f8iland, H., & Baak, J. P. A. (2019). Metabolic consequences of perioperative oral carbohydrates in breast cancer patients \u2014 an explorative study. Bmc Cancer, 19(1), 1183. https:\/\/doi.org\/10.1186\/s12885-019-6393-7","journal-title":"Bmc Cancer"},{"key":"2459_CR63","doi-asserted-by":"publisher","unstructured":"Le\u00f3n-Carre\u00f1o, L., Pardo-Rodriguez, D., Hernandez-Rodriguez, A. D. P., Ram\u00edrez-Prieto, J., L\u00f3pez-Molina, G., Claros, A. G., Cortes-Guerra, D., Alberto-Camargo, J., Rubiano-Forero, W., Sandoval-Hernandez, A., Cala, M. P., & Ondo-Mendez, A. (2025). Metabolomic analysis of breast cancer in Colombian patients: Exploring molecular signatures in different subtypes and stages. International Journal of Molecular Sciences, 26(15). https:\/\/doi.org\/10.3390\/ijms26157230","DOI":"10.3390\/ijms26157230"},{"issue":"1","key":"2459_CR64","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1021\/acs.analchem.0c04371","volume":"93","author":"MPM Letertre","year":"2021","unstructured":"Letertre, M. P. M., Dervilly, G., & Giraudeau, P. (2021). Combined nuclear magnetic resonance spectroscopy and mass spectrometry approaches for metabolomics. Analytical Chemistry, 93(1), 500\u2013518. https:\/\/doi.org\/10.1021\/acs.analchem.0c04371","journal-title":"Analytical Chemistry"},{"issue":"1","key":"2459_CR65","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41598-019-57068-5","volume":"10","author":"L Li","year":"2020","unstructured":"Li, L., Zheng, X., Zhou, Q., Villanueva, N., Nian, W., Liu, X., & Huan, T. (2020). Metabolomics-based discovery of molecular signatures for triple negative breast cancer in Asian female population. Scientific Reports, 10(1), 370. https:\/\/doi.org\/10.1038\/s41598-019-57068-5","journal-title":"Scientific Reports"},{"issue":"1","key":"2459_CR66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","volume":"52","author":"EL Lieu","year":"2020","unstructured":"Lieu, E. L., Nguyen, T., Rhyne, S., & Kim, J. (2020). Amino acids in cancer. Experimental & Molecular Medicine, 52(1), 15\u201330. https:\/\/doi.org\/10.1038\/s12276-020-0375-3","journal-title":"Experimental & Molecular Medicine"},{"issue":"22","key":"2459_CR67","doi-asserted-by":"publisher","first-page":"670","DOI":"10.21037\/atm.2019.10.34","volume":"7","author":"X Lin","year":"2019","unstructured":"Lin, X., Xu, R., Mao, S., Zhang, Y., Dai, Y., Guo, Q., Song, X., Zhang, Q., Li, L., & Chen, Q. (2019). Metabolic biomarker signature for predicting the effect of neoadjuvant chemotherapy of breast cancer. Annals of Translational Medicine, 7(22), 670\u2013670. https:\/\/doi.org\/10.21037\/atm.2019.10.34","journal-title":"Annals of Translational Medicine"},{"issue":"3","key":"2459_CR69","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s13577-024-01046-1","volume":"37","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Suhail, Y., Novin, A., Afzal, J., Pant, A., & Kshitiz (2024). Lactate in breast cancer cells is associated with evasion of hypoxia-induced cell cycle arrest and adverse patient outcome. Human Cell, 37(3), 768\u2013781. https:\/\/doi.org\/10.1007\/s13577-024-01046-1","journal-title":"Human Cell"},{"key":"2459_CR68","doi-asserted-by":"publisher","unstructured":"Liu, M., Zou, L., Zhang, N., Zhou, W., Pan, X., Deng, Y., Yue, Y., Wu, J., Liang, X., Chen, M., & Zeng, X. (2025a). Pathological response and metabolites\u2019 prognostic role in HER2-positive breast cancer treated with neoadjuvant pyrotinib, trastuzumab, nab-paclitaxel, and carboplatin: a single-arm phase II trial. Breast Cancer Research, 27(1). https:\/\/doi.org\/10.1186\/s13058-025-02137-z","DOI":"10.1186\/s13058-025-02137-z"},{"issue":"7","key":"2459_CR70","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/procel\/pwaf011","volume":"16","author":"Y Liu","year":"2025","unstructured":"Liu, Y., Zong, X., Altea-Manzano, P., & Fu, J. (2025b). Amino acid metabolism in breast cancer: pathogenic drivers and therapeutic opportunities. Protein & Cell, 16(7), 506\u2013531. https:\/\/doi.org\/10.1093\/procel\/pwaf011","journal-title":"Protein & Cell"},{"issue":"2","key":"2459_CR71","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/1099800417747411","volume":"20","author":"DE Lyon","year":"2017","unstructured":"Lyon, D. E., Starkweather, A., Yao, Y., Garrett, T., Kelly, D. L., Menzies, V., Derezi\u0144ski, P., Datta, S., Kumar, S., & Jackson-Cook, C. (2017). Pilot study of metabolomics and psychoneurological symptoms in women with early stage breast cancer. Biological Research For Nursing, 20(2), 227\u2013236. https:\/\/doi.org\/10.1177\/1099800417747411","journal-title":"Biological Research For Nursing"},{"issue":"1","key":"2459_CR72","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12905-023-02355-7","volume":"23","author":"DE Lyon","year":"2023","unstructured":"Lyon, D. E., Yao, Y., Garrett, T., Kelly, D. L., Cousin, L., & Archer, K. J. (2023). Comparison of serum metabolomics in women with breast cancer prior to chemotherapy and at 1 year: Cardiometabolic implications. BMC Women\u2019s Health, 23(1), 221. https:\/\/doi.org\/10.1186\/s12905-023-02355-7","journal-title":"BMC Women\u2019s Health"},{"key":"2459_CR73","doi-asserted-by":"publisher","unstructured":"Madssen, T. S., Cao, M. D., Pladsen, A. V., Ottestad, L., Sahlberg, K. K., Bathen, T. F., & Giske\u00f8deg\u00e5rd, G. F. (2019). Historical biobanks in breast cancer metabolomics\u2014challenges and opportunities. Metabolites. https:\/\/doi.org\/10.3390\/metabo9110278","DOI":"10.3390\/metabo9110278"},{"issue":"2","key":"2459_CR74","doi-asserted-by":"publisher","first-page":"e24212","DOI":"10.1002\/jcla.24212","volume":"36","author":"C Mao","year":"2022","unstructured":"Mao, C., Wang, M., Li, L., & Tang, J. H. (2022). Circulating metabolites serve as diagnostic biomarkers for HER2-positive breast cancer and have predictive value for trastuzumab therapy outcomes. Journal of Clinical Laboratory Analysis, 36(2), e24212. https:\/\/doi.org\/10.1002\/jcla.24212","journal-title":"Journal of Clinical Laboratory Analysis"},{"issue":"1","key":"2459_CR75","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","volume":"14","author":"UE Martinez-Outschoorn","year":"2017","unstructured":"Martinez-Outschoorn, U. E., Peiris-Pag\u00e9s, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2017). Cancer metabolism: A therapeutic perspective. Nature Reviews Clinical Oncology, 14(1), 11\u201331. https:\/\/doi.org\/10.1038\/nrclinonc.2016.60","journal-title":"Nature Reviews Clinical Oncology"},{"key":"2459_CR76","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2147\/BCTT.S466521","volume":"16","author":"AN McMahon","year":"2024","unstructured":"McMahon, A. N., Lee, E., Takita, C., Reis, I. M., Wright, J. L., & Hu, J. J. (2024). Metabolomics in radiotherapy-induced early adverse skin reactions of breast cancer patients. Breast Cancer: Targets and Therapy, 16, 369\u2013377. https:\/\/doi.org\/10.2147\/BCTT.S466521","journal-title":"Breast Cancer: Targets and Therapy"},{"key":"2459_CR77","doi-asserted-by":"publisher","first-page":"341791","DOI":"10.1016\/j.aca.2023.341791","volume":"1279","author":"TS McMillen","year":"2023","unstructured":"McMillen, T. S., Leslie, A., Chisholm, K., Penny, S., Gallant, J., Cohen, A., Drucker, A., Fawcett, J. P., & Pinto, D. M. (2023). A large-scale, targeted metabolomics method for the analysis and quantification of metabolites in human plasma via liquid chromatography-mass spectrometry. Analytica Chimica Acta, 1279, 341791. https:\/\/doi.org\/10.1016\/j.aca.2023.341791","journal-title":"Analytica Chimica Acta"},{"issue":"26","key":"2459_CR78","doi-asserted-by":"publisher","first-page":"39809","DOI":"10.18632\/oncotarget.9489","volume":"7","author":"G Miolo","year":"2016","unstructured":"Miolo, G., Muraro, E., Caruso, D., Crivellari, D., Ash, A., Scalone, S., Lombardi, D., Rizzolio, F., Giordano, A., & Corona, G. (2016). Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer. Oncotarget, 7(26), 39809\u201339822. https:\/\/doi.org\/10.18632\/oncotarget.9489","journal-title":"Oncotarget"},{"key":"2459_CR79","doi-asserted-by":"publisher","unstructured":"Nambo-Venegas, R., Enr\u00edquez-C\u00e1rcamo, V. I., Vela-Amieva, M., Ibarra-Gonz\u00e1lez, I., Lopez-Castro, L., Cabrera-Nieto, S. A., Bargall\u00f3-Rocha, J. E., Villarreal-Garza, C. M., Mohar, A., Palacios-Gonz\u00e1lez, B., Reyes-Grajeda, J. P., Fajardo-Espinoza, F. S., & Cruz-Ramos, M. (2025). A predictive model for neoadjuvant therapy response in breast cancer. Metabolomics, 21(2). https:\/\/doi.org\/10.1007\/s11306-025-02230-6","DOI":"10.1007\/s11306-025-02230-6"},{"issue":"6","key":"2459_CR80","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1007\/s00404-022-06558-5","volume":"306","author":"J Nees","year":"2022","unstructured":"Nees, J., Schafferer, S., Yuan, B., Tang, Q., Scheffler, M., Hartkopf, A., Golatta, M., Schneewei\u00df, A., Burwinkel, B., & Wallwiener, M. (2022). How previous treatment changes the metabolomic profile in patients with metastatic breast cancer. Archives of Gynecology and Obstetrics, 306(6), 2115\u20132122. https:\/\/doi.org\/10.1007\/s00404-022-06558-5","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"1\u20132","key":"2459_CR81","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/14690667221093871","volume":"28","author":"\u00d6 \u00d6zer","year":"2022","unstructured":"\u00d6zer, \u00d6., Nemutlu, E., Re\u00e7ber, T., Eylem, C. C., Aktas, B. Y., K\u0131r, S., Kars, A., & Aksoy, S. (2022). Liquid biopsy markers for early diagnosis of brain metastasis patients with breast cancer by metabolomics. European Journal of Mass Spectrometry, 28(1\u20132), 56\u201364. https:\/\/doi.org\/10.1177\/14690667221093871","journal-title":"European Journal of Mass Spectrometry"},{"issue":"1","key":"2459_CR82","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova, N. N., & Thompson, C. B. (2016). The emerging hallmarks of cancer metabolism. Cell Metabolism, 23(1), 27\u201347. https:\/\/doi.org\/10.1016\/j.cmet.2015.12.006","journal-title":"Cell Metabolism"},{"issue":"3","key":"2459_CR83","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4161\/epi.24042","volume":"8","author":"JM Phang","year":"2013","unstructured":"Phang, J. M., Liu, W., & Hancock, C. (2013). Bridging epigenetics and metabolism: Role of non-essential amino acids. Epigenetics, 8(3), 231\u2013236. https:\/\/doi.org\/10.4161\/epi.24042","journal-title":"Epigenetics"},{"issue":"20","key":"2459_CR84","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1158\/1078-0432.CCR-24-0195","volume":"30","author":"M Piffoux","year":"2024","unstructured":"Piffoux, M., Jacquemin, J., P\u00e9t\u00e9ra, M., Durand, S., Abila, A., Centeno, D., Joly, C., Lyan, B., Martin, A. L., Everhard, S., Boyault, S., Pistilli, B., Fournier, M., Rouanet, P., Havas, J., Sauterey, B., Campone, M., Tarpin, C., Mouret-Reynier, M. A., & Tr\u00e9dan, O. (2024). Metabolomic prediction of breast cancer treatment\u2013induced neurologic and metabolic toxicities. Clinical Cancer Research, 30(20), 4654\u20134666. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-0195","journal-title":"Clinical Cancer Research"},{"key":"2459_CR85","doi-asserted-by":"publisher","unstructured":"Qiu, S., Cai, Y., Yao, H., Lin, C., Xie, Y., Tang, S., & Zhang, A. (2023). Small molecule metabolites: discovery of biomarkers and therapeutic targets. Signal Transduction and Targeted Therapy. https:\/\/doi.org\/10.1038\/s41392-023-01399-3","DOI":"10.1038\/s41392-023-01399-3"},{"issue":"7578","key":"2459_CR86","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nature15529","volume":"527","author":"S Rabinovich","year":"2015","unstructured":"Rabinovich, S., Adler, L., Yizhak, K., Sarver, A., Silberman, A., Agron, S., Stettner, N., Sun, Q., Brandis, A., Helbling, D., Korman, S., Itzkovitz, S., Dimmock, D., Ulitsky, I., Nagamani, S. C. S., Ruppin, E., & Erez, A. (2015). Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis. Nature, 527(7578), 379\u2013383. https:\/\/doi.org\/10.1038\/nature15529","journal-title":"Nature"},{"key":"2459_CR87","doi-asserted-by":"publisher","first-page":"117940","DOI":"10.1016\/j.trac.2024.117940","volume":"180","author":"S Rakusanova","year":"2024","unstructured":"Rakusanova, S., & Cajka, T. (2024). Tips and tricks for LC\u2013MS-based metabolomics and lipidomics analysis. Trends in Analytical Chemistry, 180, 117940. https:\/\/doi.org\/10.1016\/j.trac.2024.117940","journal-title":"TrAC Trends in Analytical Chemistry"},{"issue":"10","key":"2459_CR88","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.ajpath.2017.04.022","volume":"187","author":"HG Russnes","year":"2017","unstructured":"Russnes, H. G., Lingj\u00e6rde, O. C., B\u00f8rresen-Dale, A. L., & Caldas, C. (2017). Breast cancer molecular stratification: From intrinsic subtypes to integrative clusters. The American Journal of Pathology, 187(10), 2152\u20132162. https:\/\/doi.org\/10.1016\/j.ajpath.2017.04.022","journal-title":"The American Journal of Pathology"},{"key":"2459_CR89","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejca.2020.08.020","volume":"139","author":"C Salvador-Coloma","year":"2020","unstructured":"Salvador-Coloma, C., Santaballa, A., Sanmart\u00edn, E., Calvo, D., Garc\u00eda, A., Herv\u00e1s, D., Cord\u00f3n, L., Quintas, G., Ripoll, F., Panadero, J., & de Font, J. (2020). Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer. European Journal of Cancer, 139, 119\u2013134. https:\/\/doi.org\/10.1016\/j.ejca.2020.08.020","journal-title":"European Journal of Cancer"},{"issue":"4","key":"2459_CR90","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1158\/1055-9965.EPI-12-1109","volume":"22","author":"JN Sampson","year":"2013","unstructured":"Sampson, J. N., Boca, S. M., Shu, X. O., Stolzenberg-Solomon, R. Z., Matthews, C. E., Hsing, A. W., Tan, Y. T., Ji, B. T., Chow, W. H., & Cai, Q. (2013). Metabolomics in epidemiology: Sources of variability in metabolite measurements and implications. Cancer Epidemiology Biomarkers & Prevention, 22(4), 631\u2013640.","journal-title":"Cancer Epidemiology Biomarkers & Prevention"},{"key":"2459_CR91","doi-asserted-by":"publisher","unstructured":"Sheikh, T. M. M., Yao, F., Liu, Z., Shafiq, M., Wu, J., Khalid, A., Xie, Q., Jiao, X., & Shen, W. (2025). Integrated insights into gut microbiota and metabolomic landscape in breast cancer patients undergoing adjuvant endocrine therapy. MSystems. https:\/\/doi.org\/10.1128\/msystems.00879-25","DOI":"10.1128\/msystems.00879-25"},{"key":"2459_CR92","doi-asserted-by":"publisher","unstructured":"Silva, A., Ap., R., Cardoso, M. R., de Oliveira, D. C., Godoy, P., Talarico, M. C. R., Guti\u00e9rrez, J. M., Peres, R., de Carvalho, R. M., Miyaguti, L. M., Sarian, N. A., Tata, L. O., Derchain, A., S. F. M., & Porcari, A. M. (2024). Plasma metabolome signatures to predict responsiveness to neoadjuvant chemotherapy in breast cancer. Cancers. https:\/\/doi.org\/10.3390\/cancers16132473","DOI":"10.3390\/cancers16132473"},{"issue":"4","key":"2459_CR93","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/nbm.1478","volume":"23","author":"B Sitter","year":"2010","unstructured":"Sitter, B., Bathen, T. F., Singstad, T. E., Fj\u00f8sne, H. E., Lundgren, S., Halgunset, J., & Gribbestad, I. S. (2010). Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy. NMR in Biomedicine, 23(4), 424\u2013431. https:\/\/doi.org\/10.1002\/nbm.1478","journal-title":"NMR in Biomedicine"},{"key":"2459_CR94","doi-asserted-by":"publisher","unstructured":"Song, H., Tang, X., Liu, M., Wang, G., Yuan, Y., Pang, R., Wang, C., Zhou, J., Yang, Y., Zhang, M., Jin, Y., Jiang, K., Wang, S., & Yin, Y. (2024). Multi-omic analysis identifies metabolic biomarkers for the early detection of breast cancer and therapeutic response prediction. IScience, 27(9). https:\/\/doi.org\/10.1016\/j.isci.2024.110682","DOI":"10.1016\/j.isci.2024.110682"},{"issue":"3","key":"2459_CR95","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s10549-009-0333-1","volume":"119","author":"ME Straver","year":"2010","unstructured":"Straver, M. E., Glas, A. M., Hannemann, J., Wesseling, J., van de Vijver, M. J., Rutgers, E. J., Th., V., Peeters, M. J. T. F. D., van Tinteren, H., van\u2018t Veer, L. J., & Rodenhuis, S. (2010). The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer. Breast Cancer Research and Treatment, 119(3), 551\u2013558. https:\/\/doi.org\/10.1007\/s10549-009-0333-1","journal-title":"Breast Cancer Research and Treatment"},{"issue":"3","key":"2459_CR96","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10549-018-4862-3","volume":"171","author":"Y Sun","year":"2018","unstructured":"Sun, Y., Kim, J. H., Vangipuram, K., Hayes, D. F., Smith, E. M. L., Yeomans, L., Henry, N. L., Stringer, K. A., & Hertz, D. L. (2018). Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy. Breast Cancer Research and Treatment, 171(3), 657\u2013666. https:\/\/doi.org\/10.1007\/s10549-018-4862-3","journal-title":"Breast Cancer Research and Treatment"},{"issue":"3","key":"2459_CR97","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"1","key":"2459_CR98","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12929-020-00679-2","volume":"27","author":"T Takahara","year":"2020","unstructured":"Takahara, T., Amemiya, Y., Sugiyama, R., Maki, M., & Shibata, H. (2020). Amino acid-dependent control of mTORC1 signaling: A variety of regulatory modes. Journal of Biomedical Science, 27(1), 87. https:\/\/doi.org\/10.1186\/s12929-020-00679-2","journal-title":"Journal of Biomedical Science"},{"key":"2459_CR99","doi-asserted-by":"publisher","unstructured":"Talarico, M. C. R., Derchain, S., da Silva, L. F., Sfor\u00e7a, M. L., Rocco, S. A., Cardoso, M. R., & Sarian, L. O. (2024). Metabolomic profiling of breast cancer patients undergoing neoadjuvant chemotherapy for predicting disease-free and overall survival. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms25168639","DOI":"10.3390\/ijms25168639"},{"issue":"19","key":"2459_CR100","doi-asserted-by":"publisher","first-page":"5972","DOI":"10.1158\/1078-0432.CCR-19-0094","volume":"25","author":"W Tang","year":"2019","unstructured":"Tang, W., Putluri, V., Ambati, C. R., Dorsey, T. H., Putluri, N., & Ambs, S. (2019). Liver- and microbiome-derived bile acids accumulate in human breast tumors and inhibit growth and improve patient survival. Clinical Cancer Research, 25(19), 5972\u20135983. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-0094","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"2459_CR101","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.molonc.2012.05.003","volume":"6","author":"L Tenori","year":"2012","unstructured":"Tenori, L., Oakman, C., Claudino, W. M., Bernini, P., Cappadona, S., Nepi, S., Biganzoli, L., Arbushites, M. C., Luchinat, C., Bertini, I., & Di Leo, A. (2012). Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: A pilot study. Molecular Oncology, 6(4), 437\u2013444. https:\/\/doi.org\/10.1016\/j.molonc.2012.05.003","journal-title":"Molecular Oncology"},{"issue":"1","key":"2459_CR102","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.molonc.2014.07.012","volume":"9","author":"L Tenori","year":"2015","unstructured":"Tenori, L., Oakman, C., Morris, P. G., Gralka, E., Turner, N., Cappadona, S., Fornier, M., Hudis, C., Norton, L., Luchinat, C., & Di Leo, A. (2015). Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study. Molecular Oncology, 9(1), 128\u2013139. https:\/\/doi.org\/10.1016\/j.molonc.2014.07.012","journal-title":"Molecular Oncology"},{"issue":"6","key":"2459_CR103","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.mencom.2015.11.019","volume":"25","author":"AM Tsedilin","year":"2015","unstructured":"Tsedilin, A. M., Fakhrutdinov, A. N., Eremin, D. B., Zalesskiy, S. S., Chizhov, A. O., Kolotyrkina, N. G., & Ananikov, V. P. (2015). How sensitive and accurate are routine NMR and MS measurements? Mendeleev Communications, 25(6), 454\u2013456. https:\/\/doi.org\/10.1016\/j.mencom.2015.11.019","journal-title":"Mendeleev Communications"},{"issue":"24","key":"2459_CR104","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1038\/onc.2015.381","volume":"35","author":"M van Geldermalsen","year":"2016","unstructured":"van Geldermalsen, M., Wang, Q., Nagarajah, R., Marshall, A. D., Thoeng, A., Gao, D., Ritchie, W., Feng, Y., Bailey, C. G., Deng, N., Harvey, K., Beith, J. M., Selinger, C. I., O\u2019Toole, S. A., Rasko, J. E. J., & Holst, J. (2016). ASCT2\/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. Oncogene, 35(24), 3201\u20133208. https:\/\/doi.org\/10.1038\/onc.2015.381","journal-title":"Oncogene"},{"issue":"4","key":"2459_CR106","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/humrep\/deq011","volume":"25","author":"M Wallace","year":"2010","unstructured":"Wallace, M., Hashim, Y. Y., Wingfield, M., Culliton, M., McAuliffe, F., Gibney, M. J., & Brennan, L. (2010). Effects of menstrual cycle phase on metabolomic profiles in premenopausal women. Human Reproduction, 25(4), 949\u2013956.","journal-title":"Human Reproduction"},{"issue":"4","key":"2459_CR107","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cmet.2022.02.010","volume":"34","author":"H Wang","year":"2022","unstructured":"Wang, H., Rong, X., Zhao, G., Zhou, Y., Xiao, Y., Ma, D., Jin, X., Wu, Y., Yan, Y., Yang, H., Zhou, Y., Qian, M., Niu, C., Hu, X., Li, D. Q., Liu, Q., Wen, Y., Jiang, Y. Z., Zhao, C., & Shao, Z. M. (2022). The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer. Cell Metabolism, 34(4), 581\u2013594e8. https:\/\/doi.org\/10.1016\/j.cmet.2022.02.010","journal-title":"Cell Metabolism"},{"key":"2459_CR109","doi-asserted-by":"publisher","unstructured":"Wang, L., Zhang, S., & Wang, X. (2021). The metabolic mechanisms of breast cancer metastasis. Frontiers in Oncology. https:\/\/doi.org\/10.3389\/fonc.2020.602416","DOI":"10.3389\/fonc.2020.602416"},{"issue":"1","key":"2459_CR108","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12929-025-01132-y","volume":"32","author":"L Wang","year":"2025","unstructured":"Wang, L., Shi, F., Cao, Y., & Xie, L. (2025). Multiple roles of branched-chain amino acid metabolism in tumour progression. Journal of Biomedical Science, 32(1), 41. https:\/\/doi.org\/10.1186\/s12929-025-01132-y","journal-title":"Journal of Biomedical Science"},{"issue":"3","key":"2459_CR110","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.molonc.2012.10.003","volume":"7","author":"S Wei","year":"2013","unstructured":"Wei, S., Liu, L., Zhang, J., Bowers, J., Gowda, G. A. N., Seeger, H., Fehm, T., Neubauer, H. J., Vogel, U., Clare, S. E., & Raftery, D. (2013). Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer. Molecular Oncology, 7(3), 297\u2013307. https:\/\/doi.org\/10.1016\/j.molonc.2012.10.003","journal-title":"Molecular Oncology"},{"issue":"1","key":"2459_CR111","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40364-026-00898-z","volume":"14","author":"P Wu","year":"2026","unstructured":"Wu, P., Zhang, J., Jiang, Z., Liu, X., Jiang, N., Zou, J., Chen, X., Wu, D., & Li, Y. (2026). Lactate-lactylation in tumor angiogenesis and progression: Mechanisms, biomarker potential, and therapeutic implications. Biomarker Research, 14(1), 21. https:\/\/doi.org\/10.1186\/s40364-026-00898-z","journal-title":"Biomarker Research"},{"issue":"5","key":"2459_CR112","doi-asserted-by":"publisher","first-page":"e95749","DOI":"10.1371\/journal.pone.0095749","volume":"9","author":"Q Xiao","year":"2014","unstructured":"Xiao, Q., Moore, S. C., Boca, S. M., Matthews, C. E., Rothman, N., Stolzenberg-Solomon, R. Z., Sinha, R., Cross, A. J., & Sampson, J. N. (2014). Sources of variability in metabolite measurements from urinary samples. PLOS ONE, 9(5), e95749. https:\/\/doi.org\/10.1371\/journal.pone.0095749","journal-title":"PLOS ONE"},{"issue":"23","key":"2459_CR113","doi-asserted-by":"publisher","first-page":"e25124","DOI":"10.1002\/jcla.25124","volume":"38","author":"N Xie","year":"2024","unstructured":"Xie, N., Liao, D., Liu, B., Zhang, J., Liu, L., Huang, G., & Ouyang, Q. (2024). Interpretable machine learning algorithms identify inetetamab-mediated metabolic signatures and biomarkers in treating breast cancer. Journal of Clinical Laboratory Analysis, 38(23), e25124. https:\/\/doi.org\/10.1002\/jcla.25124","journal-title":"Journal of Clinical Laboratory Analysis"},{"key":"2459_CR115","doi-asserted-by":"publisher","first-page":"128327","DOI":"10.1016\/j.talanta.2025.128327","volume":"295","author":"R Xu","year":"2025","unstructured":"Xu, R., & Zhu, J. (2025). Unveiling the dark matter of the metabolome: A narrative review of bioinformatics tools for LC-HRMS-based compound annotation. Talanta, 295, 128327. https:\/\/doi.org\/10.1016\/j.talanta.2025.128327","journal-title":"Talanta"},{"key":"2459_CR114","doi-asserted-by":"publisher","unstructured":"Xu, E., Ji, B., Jin, K., & Chen, Y. (2023). Branched-chain amino acids catabolism and cancer progression: Focus on therapeutic interventions. Frontiers in Oncology, Volume 13-2023. https:\/\/doi.org\/10.3389\/fonc.2023.1220638","DOI":"10.3389\/fonc.2023.1220638"},{"issue":"2","key":"2459_CR116","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10549-024-07370-2","volume":"207","author":"M Yamada","year":"2024","unstructured":"Yamada, M., Jinno, H., Naruse, S., Isono, Y., Maeda, Y., Sato, A., Matsumoto, A., Ikeda, T., & Sugimoto, M. (2024). Predictive analysis of breast cancer response to neoadjuvant chemotherapy through plasma metabolomics. Breast Cancer Research and Treatment, 207(2), 393\u2013404. https:\/\/doi.org\/10.1007\/s10549-024-07370-2","journal-title":"Breast Cancer Research and Treatment"},{"key":"2459_CR117","doi-asserted-by":"publisher","first-page":"117706","DOI":"10.1016\/j.bcp.2026.117706","volume":"246","author":"T Yamauchi","year":"2026","unstructured":"Yamauchi, T., Fukuzaki, R., Takahata, Y., Okano, Y., Suzuki, K., Tsuruta, A., Ohdo, S., & Koyanagi, S. (2026). Valine availability controls oncogenic cell-cycle progression through translation of D-type cyclins. Biochemical Pharmacology, 246, 117706. https:\/\/doi.org\/10.1016\/j.bcp.2026.117706","journal-title":"Biochemical Pharmacology"},{"issue":"4","key":"2459_CR118","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s12282-024-01579-1","volume":"31","author":"PJ Yang","year":"2024","unstructured":"Yang, P. J., Tsai, E. M., Hou, M. F., Lee, Y. J., & Wang, T. N. (2024). Global untargeted and individual targeted plasma metabolomics of breast cancer recurrence modified by hormone receptors. Breast Cancer, 31(4), 659\u2013670. https:\/\/doi.org\/10.1007\/s12282-024-01579-1","journal-title":"Breast Cancer"},{"issue":"12","key":"2459_CR119","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.7150\/jca.113235","volume":"16","author":"X Yang","year":"2025","unstructured":"Yang, X., Feng, Y., Wang, R., Zeng, X., Gao, B., Huang, P., Chen, H., & Zeng, W. (2025). Spermidine potentiates anti-tumor immune responses and immunotherapy sensitivity in breast cancer. Journal of Cancer, 16(12), 3684\u20133695. https:\/\/doi.org\/10.7150\/jca.113235","journal-title":"Journal of Cancer"},{"issue":"4","key":"2459_CR120","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.molcel.2015.04.021","volume":"58","author":"N Zamboni","year":"2015","unstructured":"Zamboni, N., Saghatelian, A., & Patti, G. J. (2015). Defining the metabolome: Size, flux, and regulation. Molecular Cell, 58(4), 699\u2013706. https:\/\/doi.org\/10.1016\/j.molcel.2015.04.021","journal-title":"Molecular Cell"},{"issue":"7","key":"2459_CR121","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11306-023-02024-8","volume":"19","author":"A Zapater-Moros","year":"2023","unstructured":"Zapater-Moros, A., D\u00edaz-Beltr\u00e1n, L., G\u00e1mez-Pozo, A., Trilla-Fuertes, L., Lumbreras-Herrera, M. I., L\u00f3pez-Camacho, E., Gonz\u00e1lez-Olmedo, C., Espinosa, E., Zamora, P., S\u00e1nchez-Rovira, P., & Fresno Vara, J. \u00c1. (2023). Metabolomics unravels subtype-specific characteristics related to neoadjuvant therapy response in breast cancer patients. Metabolomics, 19(7), 60. https:\/\/doi.org\/10.1007\/s11306-023-02024-8","journal-title":"Metabolomics"},{"issue":"1","key":"2459_CR122","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13058-024-01813-w","volume":"26","author":"N Zhang","year":"2024","unstructured":"Zhang, N., Huang, Y., Wang, G., Xiang, Y., Jing, Z., Zeng, J., Yu, F., Pan, X., Zhou, W., & Zeng, X. (2024). Metabolomics assisted by transcriptomics analysis to reveal metabolic characteristics and potential biomarkers associated with treatment response of neoadjuvant therapy with TCbHP regimen in HER2\u2009+\u2009breast cancer. Breast Cancer Research, 26(1), 64. https:\/\/doi.org\/10.1186\/s13058-024-01813-w","journal-title":"Breast Cancer Research"},{"key":"2459_CR123","doi-asserted-by":"publisher","first-page":"101534","DOI":"10.1016\/j.tranon.2022.101534","volume":"26","author":"X Zheng","year":"2022","unstructured":"Zheng, X., Ma, H., Wang, J., Huang, M., Fu, D., Qin, L., & Yin, Q. (2022). Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets. Translational Oncology, 26, 101534. https:\/\/doi.org\/10.1016\/j.tranon.2022.101534","journal-title":"Translational Oncology"},{"key":"2459_CR124","doi-asserted-by":"publisher","unstructured":"Zhuang, W., Lai, X., Mai, Q., Ye, S., Chen, J., Liu, Y., Wang, J., Li, S., Huang, Y., Qin, T., Hu, H., Wu, J., & Yao, H. (2022). Biomarkers of PEGylated liposomal doxorubicin-induced hypersensitivity reaction in breast cancer patients based on metabolomics. Frontiers in Pharmacology, 13. https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/https:\/\/doi.org\/10.3389\/fphar.2022.827446","DOI":"10.3389\/fphar.2022.827446"},{"key":"2459_CR125","doi-asserted-by":"publisher","unstructured":"Zidi, O., Souai, N., Raies, H., Ben Ayed, F., Mezlini, A., Mezrioui, S., Tranchida, F., Sabatier, J. M., Mosbah, A., Cherif, A., Shintu, L., & Kouidhi, S. (2021). Fecal metabolic profiling of breast cancer patients during neoadjuvant chemotherapy reveals potential biomarkers. Molecules. https:\/\/doi.org\/10.3390\/molecules26082266","DOI":"10.3390\/molecules26082266"}],"container-title":["Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-026-02459-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11306-026-02459-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-026-02459-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:20:43Z","timestamp":1788459643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11306-026-02459-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":123,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2459"],"URL":"https:\/\/doi.org\/10.1007\/s11306-026-02459-9","relation":{},"ISSN":["1573-3890"],"issn-type":[{"value":"1573-3890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"115"}}